Dr. Rodney S. Markin

Dr. Rodney S. Markin

Chair of the BoardatCardiff Oncology· In proxies 2023–2025

Dr. Rodney S. Markin sits on 5 public boards.

Boards1

  • Cardiff OncologyChair · 11 yr on the boardIndependentAudit, Compensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Cardiff OncologyPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrStock in role -29%
  2. PerceptiMedPublic company · 11 yr
    • Director2015 – Present · 11 yrNo stock prices for these years
  3. Nebraska Health PartnersPublic company
    • Director? – PresentNo stock prices for these years
  4. UNMC PhysiciansPublic company
    • Director? – PresentNo stock prices for these years
  5. Directors for Transgenomic, Inc.Public company · 7 yr
    • Director2007 – 2014 · 7 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?